To address this issue, RVG (rabies virus glycoprotein)-9r peptide-modified LNPs were developed and loaded with siRNA against mutant ataxin-3, a Machado-Joseph disease (MJD) causing protein, for testing their therapeutic effect in a MJD mouse model (Conceição et al.2016). The gene discussed is ART4; the disease is Machado-Joseph disease.